Skip to content

Clinical trials

Head and Neck Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Country / region: Germany Clear all

113 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20043
20053
20063
20071
20082
20091
20102
20114
20123
20131
20143
201510
20163
201712
20187
20196
202012
20215
20226
20236
20247
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Recruiting22
Terminated19
Active, not recruiting12
Unknown status7
Not yet recruiting3
Suspended1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC6
Technische Universität Dresden6
AstraZeneca5
Eli Lilly and Company5
GlaxoSmithKline5
University of Erlangen-Nürnberg Medical School5
Charite University, Berlin, Germany4
University Hospital Tuebingen4
Hoffmann-La Roche3
University Hospital Heidelberg3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms113
Squamous Cell Carcinoma of Head and Neck31
Carcinoma, Non-Small-Cell Lung14
Neoplasms13
Breast Neoplasms11
Colorectal Neoplasms11
Esophageal Neoplasms9
Lung Neoplasms9
Colonic Neoplasms8
Melanoma8

Trials

Showing 76 to 100 of 113. Each trial links to its page on Pharma Observatory.

13 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.